CI-1021

CI-1021 is a chemical compound that has been investigated for its potential use in the treatment of various medical conditions. It is primarily known as a selective antagonist of the neurokinin-1 receptor (NK1 receptor), which is involved in the modulation of pain and inflammation, as well as the regulation of mood and anxiety.

Pharmacology

CI-1021 functions by blocking the action of substance P, a neuropeptide that binds to the NK1 receptor. Substance P is associated with the transmission of pain signals and the regulation of emotional responses. By inhibiting this interaction, CI-1021 may reduce pain and have anxiolytic effects.

Clinical Research

Research into CI-1021 has focused on its potential applications in treating conditions such as chronic pain, depression, and anxiety disorders. However, as of the latest updates, CI-1021 has not been approved for clinical use, and its development status remains uncertain.

Mechanism of Action

The NK1 receptor is a G-protein coupled receptor that, when activated by substance P, initiates a cascade of intracellular events leading to the sensation of pain and the modulation of mood. CI-1021, by acting as an antagonist, prevents these effects by blocking the receptor.

Potential Applications

• Pain Management: CI-1021 has been studied for its potential to alleviate chronic pain conditions by interfering with the pain signaling pathways.
• Psychiatric Disorders: Due to its effects on mood regulation, CI-1021 has been explored as a treatment for depression and anxiety.

Safety and Efficacy

The safety profile of CI-1021 has been evaluated in preclinical studies, but comprehensive clinical trials are necessary to establish its efficacy and safety in humans. Potential side effects and long-term impacts remain areas of active research.

Also see

• Neurokinin-1 receptor antagonist
• Substance P
• Chronic pain management
• Anxiolytic

Receptor Antagonists
Receptor Type	Example Antagonists
Adrenergic receptor	Propranolol, Prazosin
Cholinergic receptor	Atropine, Scopolamine
Dopamine receptor	Haloperidol, Clozapine
Histamine receptor	Ranitidine, Diphenhydramine
Serotonin receptor	Ondansetron, Risperidone
Glutamate receptor	Memantine, Ketamine
GABA receptor	Flumazenil, Bicuculline
Opioid receptor	Naloxone, Naltrexone
Angiotensin receptor	Losartan, Valsartan